Combination therapy in the management of HIV infection

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue SUPPL. C, 1996, Pages 23-26

  Vella, S ^a   Franca Pirillo, M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; INDINAVIR; NEVIRAPINE; RNA; ZIDOVUDINE;

CONFERENCE PAPER; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION;

ANTI-HIV AGENTS; ANTIGENS, CD4; CLINICAL TRIALS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; GUIDELINES; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; VIRUS REPLICATION;

EID: 0029729543     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Bartlett, J.A., Benoit, S.L., Johnson, V.A. et al. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. Ann Int Med 1996, 125: 161-172.
2. Carpenter, C.C.J., Fischl, M.A., Hammer, S.M. et al. Antiretroviral therapy for HIV infection in 1996. Recommendation of an international panel. JAMA 1996, 276: 146-154.
3. CDC. Update: Provisional public health service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR 1996, 45: 468-472.
4. Collier, A.C., Coombs, R.W., Schoenfeld, D.A. et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl J Med 1996, 334: 1011-1017.
5. D'Aquila, r.T., Hughes, M.D., Johnson, V.A. et al. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV infection. Ann Int Med 1996, 124: 1019-1030.
6. Delta Coordinating Committee. Delta: A randomized double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996, 348: 283-291.
7. Dolin, R., Amato, D.A., Fischl, M.A. et al. Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. Arch Int Med 1995, 155: 961-974.
8. Eron, J.J., Benoit, S.L., Jemsek, J. et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4 per cubic millimeter. N Engl J Med 1995, 333: 1662-1669.
9. Gulick, R., Mellors, J., Havlir, D. et al. Potent and sustained antiretroviral activity of indinavir (IDV) in combination with zidovudine (ZDV) and lamivudine (3TC). In: Program and Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections. January 28-February 1, 1996, Washington DC, Abstract LB7.
10. Ho, D.D., Neumann, A.U., Perelson, A.S. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV infection. Nature 1995, 373: 123-126.
11. Katlama, C., Ingrand, D., Loveday, C. et al. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. JAMA 1996, 276: 118-125.
12. Mellors, J.W., Kinsley, L.A., Rinaldo, C.R. Jr. et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272: 1167-1170.
13. Mellors, J.W., Kinsley, L.A., Rinaldo, C.R. Jr. et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Int Med 1995, 122: 573-579.
14. O'Brien, W.A., Hartigan, P.M., Martin, D., Esinart, J. Changes in plasma HIV-1 RNA and CD4 lymphocyte count relative to treatment and progression to AIDS. N Engl J Med 1996, 334: 426-431.
15. Perelson, A.S., Neumann, A.U., Markowitz, M. et al. HIV-1 dynamics in vivo: Virion clearance rate, infected cell span, and viral generation time. Science 1996, 271: 1582-1586.
16. Pollard, R., Peterson, D., Hardy, D. et al. Antiviral effect and safety of stavudine (d4T) and didanosine (ddl) combination therapy in HIV-infected subjects in an ongoing pilot randomized double-blind tria. In: Program and Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections. January 28-February 1, 1996, Washington DC, Abstract 197.
17. Richman, D.D. HIV therapeutics. Nature 1996, 272: 1886-1888.
18. Saag, M.S., Holodniy, M., Kuritkes, D.R. et al. HIV viral load markers in clinial practice: Recommendations of an international AIDS Society-USA Expert panel. Nat Med 1996, 2: 625-629.
19. Schacker, T., Collier, A.C., Hughes, J.H. et al. Clinical and epidemiological features of primary HIV infection. Ann Int Med 1996, 125: 257-264.
20. Schooley, R.T., Ramírez-Ronda, c., Lange, J.M.A. et al. Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared to zidovudine monotherapy. J Infect Dis 1996, 173: 1354-1366.
21. Staszewski, S., Loveday, c., Picazo, J.J. et al. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. JAMA 1996, 276: 111-117.
22. Wei, X., Ghosh, S.K., Taylor, M.E. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373: 117-122.